Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10
Closed -$121K 6798
2021
Q4
$121K Buy
10
+7
+233% +$87.9K ﹤0.01% 6084
2021
Q3
$45K Sell
3
-5
-63% -$58.9K ﹤0.01% 6067
2021
Q2
$109K Buy
+8
New +$141K ﹤0.01% 5923
2021
Q1
Sell
-3
Closed -$59K 6250
2020
Q4
$59K Buy
+3
New +$72.1K ﹤0.01% 5359
2017
Q4
Sell
-13
Closed -$1.23M 6547
2017
Q3
$1.23M Buy
+13
New +$1.12M ﹤0.01% 4408

Other funds holding NCNA

Goldman Sachs's NCNA Position: Q1 2022 in Review

Goldman Sachs sold out of NuCana (NCNA) in Q1 2022, closing a stake of 10 shares — an estimated $121K sold.

Goldman Sachs first reported a position in NCNA in Q3 2017 and held it in 5 quarters. The position peaked at $1.23M in Q3 2017. 27 funds tracked by Wall St. Rank hold NCNA as of Q1 2022.

  • Goldman Sachs reported no remaining NuCana position as of Q1 2022 after selling out during the quarter.
  • Goldman Sachs sold 10 NuCana shares in Q1 2022, an estimated $121K.
  • Goldman Sachs first reported a position in NuCana in Q3 2017 and held it in 5 quarters.
  • Goldman Sachs's NuCana position peaked at $1.23M in Q3 2017.
  • 27 funds tracked by Wall St. Rank held NuCana as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.